Anthony Barsotti, Ph.D.

3DC – Senior Director, Preclinical Pharmacology

• LinkedIn

Anthony Barsotti, Ph.D., is a senior director, preclinical pharmacology at Deerfield Discovery and Development. Prior to Deerfield, Anthony served as director of target discovery biology at Inzen Therapeutics. Before Inzen, he was a principal scientist (molecular signaling) at Kadmon Corporation. He began his career as a post-doctoral fellow at Pfizer in the oncology research unit. Anthony holds a bachelor’s in biochemistry from the University of Pennsylvania and a doctorate in biological sciences from Columbia University.